deltatrials
Terminated PHASE2 NCT00120783

Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance

Efficacy and Tolerability of an Antiretroviral bi-Therapy in HIV-1 Infected Patients With Multidrug Resistant HIV ANRS 109 Vista Trial.

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis

Conditions HIV Infections
Interventions Indinavir Lamivudine Ritonavir
Updated 5 times since 2017 Last updated: Jan 17, 2007 Started: Feb 28, 2002 Completion: Aug 31, 2003

This PHASE2 trial investigates HIV Infections and is currently terminated or withdrawn. French National Agency for Research on AIDS and Viral Hepatitis leads this study, which shows 5 recorded versions since 2002 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE2

    First recorded

Feb 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • French National Agency for Research on AIDS and Viral Hepatitis
Data source: French National Agency for Research on AIDS and Viral Hepatitis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Bobigny, France